Online Program Home
My Program

Abstract Details

Activity Number: 228 - Innovative Statistical Designs with Real Life Case Studies for New Paradigms in Oncology Drug Development
Type: Topic Contributed
Date/Time: Monday, July 30, 2018 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract #330741 Presentation
Title: GBM AGILE: a Phase II/III Platform Design with Signature Identification
Author(s): Todd Graves* and Donald A Berry and Jason Connor
Companies: Berry Consultants LLC and Berry Consultants and M.D. Anderson Cancer Center and ConfluenceStat LLC
Keywords: Adaptive clinical trial; Platform trial; Predictive probability; Population enrichment

GBM AGILE is a platform trial in glioblastoma multiforme. Its design features therapies that enter and exit the trial at different times, and it combines the inferential tasks of screening new therapies for efficacy, identifying populations who benefit from therapies, and confirming treatment effects. This talk will introduce the GBM AGILE design and discuss some of its features and some of the challenges in its development.

Authors who are presenting talks have a * after their name.

Back to the full JSM 2018 program